Internal Medicine, Nephrology · Orange, CA
NPI
1326086695
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1100 W Stewart Dr
Orange, CA, 92868
Phone (714) 771-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$104K
1,455 services
Medicare patients, 2024
318
Average age 58
Drug cost, 2024
$3.6M
3,095 prescriptions
Company payments, 2025
$106K
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yasir A Qazi was code 99213 (office e&m - established), 263 times for 108 patients. In total Yasir A Qazi billed 1,455 services in 14 codes, and Medicare paid $104K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 263 | 108 | $54.39 | $14K |
| 99213 Office E&M - Established | Office | 212 | 112 | $78.59 | $17K |
| 99214 Office E&M - Established | Office | 152 | 99 | $99.63 | $15K |
| 99214 Office E&M - Established | Facility | 140 | 58 | $77.81 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 126 | 58 | $64.95 | $8,184 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 103 | 85 | $13.57 | $1,397 |
| 99215 Office E&M - Established | Office | 102 | 77 | $154.64 | $16K |
| 99215 Office E&M - Established | Facility | 101 | 68 | $114.76 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 80 | 63 | $13.70 | $1,096 |
| 99212 Office E&M - Established | Office | 72 | 60 | $48.71 | $3,507 |
| 99212 Office E&M - Established | Facility | 66 | 49 | $29.13 | $1,922 |
By year: 2022 $40K for 577 services; 2023 $118K for 1,211 services; 2024 $104K for 1,455 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yasir A Qazi prescribed most often to Medicare patients was Pantoprazole Sodium, with 332 prescriptions and refills. In total Yasir A Qazi wrote 3,095 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 332 | 428 | 72 | $2,226 |
| Valganciclovir Hcl Generic | 303 | 341 | 89 | $44K |
| Amlodipine Besylate Generic | 237 | 306 | 56 | $412 |
| Losartan Potassium Generic | 152 | 207 | 39 | $566 |
| Prednisone Generic | 125 | 147 | 38 | $446 |
| Cinacalcet Hcl Generic | 124 | 130 | 23 | $41K |
| Tamsulosin Hcl Generic | 121 | 170 | 25 | $1,253 |
| Atorvastatin Calcium Generic | 118 | 161 | 31 | $344 |
| Allopurinol Generic | 89 | 110 | 18 | $418 |
| Labetalol Hcl Generic | 83 | 91 | 17 | $1,388 |
| Filspari Sparsentan | 78 | 78 | 14 | $1.1M |
| Metoprolol Tartrate Generic | 57 | 74 | 11 | $190 |
| Carvedilol Generic | 56 | 62 | 15 | $169 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 56 | 149 | 23 | $4,715 |
| Zarxio Filgrastim-Sndz | 52 | 52 | 32 | $55K |
Brand drugs: 665 claims; generic drugs: 2,372 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yasir A Qazi $106K ($106K in general payments such as food, travel and fees) from 25 companies. The largest payer was Travere Therapeutics, Inc. with $51K.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 60 | $51K |
| Merck Sharp & Dohme LLC MRK | 25 | $16K |
| Biogen, Inc. BIIB | 3 | $8,794 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $7,919 |
| Amgen Inc. AMGN | 33 | $7,616 |
| Sobi, Inc SOBI.ST | 4 | $6,745 |
| Calliditas Therapeutics US Inc. | 7 | $4,578 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $2,161 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $292 |
| Alnylam Pharmaceuticals Inc. ALNY | 6 | $214 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.